Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Event
Pre-ESMO 2023 Symposium | Accelerating the Impact of the Cancer Mission Five-Fold: Where Europe Should Invest to Improve Cancer Outcomes in 10 Years Instead of 50
calendar

October 20, 2023

Calendar
clock

GMT

map point

Hotel Silken Puerta Madrid, Juan Rizi Street, 5. 28027, Madrid

Madrid, Spain

View map
Register

View all IQVIA events
View now

Background: Medical oncologists focused on advancing research and treatment options for patients recognize the importance of balancing investment in innovative therapeutics and providing patients access to these with the need to ensure the sustainability of health systems. The Horizon Europe Mission on Cancer and Europe’s Beating Cancer Plan as well as the European Pharmaceutical Strategy are all intended to bring improved outcomes to patients but often with timelines that stretch decades into the future. At the same time, investment levels are constrained by macroeconomic factors, and policymakers must make tough decisions as to where to invest to achieve maximum societal returns.

This symposium will bring together a multi-stakeholder panel to propose ways to accelerate the impact of cost-effective efforts to improve cancer outcomes five-fold – reducing what might take 50 years to only 10 years. It aligns with the aims of the ESMO Congress in Madrid – Good Science, Better Medicine, Best Practice.

Register to attend in-person or virtually.

Format: The symposium will begin with a short 15-minute presentation by the IQVIA Institute to set the stage and provide an evidence base that can inform the subsequent discussion. Panelists will be invited to share their perspectives and respond to questions. We expect an interactive, engaging dialogue.

Potential areas of discussion:
Diagnostics for the precision medicine era

What bottlenecks to optimal care exist in the diagnostics and care delivery area and how much impact could be achieved by reducing or removing these barriers within a decade?

What stops every European patient from getting a modern diagnostic test?

What is the cost of "not testing"?

Where are there low-hanging fruit policy makers should prioritize for improvement and investment that can provide rapid and broad improvement to patient care?

Driving improvements in surgery and radiotherapy What potential do these modalities have to improve cancer care?

Are we making the right level of investment in public R&D efforts relative to their potential?

How do we better champion the development and implementation of innovative surgical and radiotherapy approaches?

How can we more quickly disseminate emerging best practice?

Conducting pragmatic trials to accelerate repurposing and label expansion

Where are the opportunities to bring existing therapies more quickly to patients?

How might pragmatic clinical trials be designed to accelerate evidence development and what magnitude of benefit can be achieved?

What regulatory changes or flexibility might be needed to accommodate non-traditional trial approaches?

What lessons have already been learned about pragmatic trials that can applied more broadly?

Contact Us